Cargando…
Silent hypoxia: higher NO in red blood cells of COVID-19 patients
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has spread to almost 100 countries, infected over 31 M patients and resulted in 961 K deaths worldwide as of 21st September 2020. The major clinical feature of severe COVID-19 req...
Autores principales: | Mortaz, Esmaeil, Malkmohammad, Majid, Jamaati, Hamidreza, Naghan, Parisa Adimi, Hashemian, Seyed MohamadReza, Tabarsi, Payam, Varahram, Maohammad, Zaheri, Hamidreza, Chousein, Efsun Gonca Uğur, Folkerts, Gert, Adcock, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563910/ https://www.ncbi.nlm.nih.gov/pubmed/33066765 http://dx.doi.org/10.1186/s12890-020-01310-8 |
Ejemplares similares
-
Correction to: Silent hypoxia: higher NO in red blood cells of COVID-19 patients
por: Mortaz, Esmaeil, et al.
Publicado: (2020) -
The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020) -
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
COVID-19: Molecular and Cellular Response
por: Alipoor, Shamila D., et al.
Publicado: (2021) -
Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019)